tykhr
sign in
free sign up
Adamas Pharmaceuticals Inc
Drug Manufacturers-Specialty & Generic
Healthcare
ADMS
35.17M shares
NASDAQ US
traded
23 Nov 2021
open
8.24
52 week high
8.23
high
8.25
52 week low
4.15
low
8.18
growth
68.1%
previous Close
8.16
P/E ratio
-30
market cap
217M
div yield
0
usd
Jun 2021
qoq
revenue
21.97M
13.78 %
net incoming
-12.34M
1.82 %
eps
-0.27
25.00 %
eps surprise
8.88 %
net profit margin
-56.18 %
8.00 %
operating incoming
-9.16M
3.88 %
net change in cash
17.14M
-67.77 %
cash on hand
88.80M
-28.87 %
cost of revenue
527K
36.88 %
top